52-Week Results From the VERIFY Clinical Trial of Rusfertide in Patients With Polycythemia Vera by Madaline Spencer| Published on: Feb 9, 2026

52-Week Results From the VERIFY Clinical Trial of Rusfertide in Patients With Polycythemia Vera by Madaline Spencer| Published on: Feb 9, 2026 Andrew T. Kuykendall, MD, VERIFY Lead Investigator and Associate Member in the Department of Hematology at Moffitt Cancer Center, discusses 52-week results from the VERIFY clinical trial testing rusfertide in patients with polycythemia vera (PV). https://checkrare.com/52-week-results-from-the-verify-clinical-trial-of-rusfertide-in-patients-with-polycythemia-vera/